Jump to content

Martin J. Lohse

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Rodw (talk | contribs) at 17:03, 27 April 2024 (Disambiguating links to Cell (link changed to Cell (journal); link changed to Cell (journal)) using DisamAssist.). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Martin J. Lohse (born 26 August 1956) is a German physician and pharmacologist.

Career

[edit]

Lohse performs ongoing research on G protein-coupled receptors. Since 1993, he is a Professor of Pharmacology at the University of Würzburg, Germany, retired in 2022, and he was the Founding Chairman of the Rudolf Virchow Center (2001–2016). From 2016 to 2019, he was Chairman of the Board and Scientific Director of the Max Delbrück Center in Berlin, a national research center of the Helmholtz Association for molecular medicine.[1][2] In 2017, he also became Speaker of the Board of the Berlin Institute of Health, a joint research center of the Max Delbrück Center and the Charité. Since 2020 he is chairman and managing director of ISAR Bioscience Institute, a translational research institute in Planegg/Munich.

Lohse received his exam in medicine as well as his M.D. from the University of Göttingen, and did research in pharmacology at the University of Heidelberg, Duke University and the GeneCenter in Munich. His research focusses on the role of receptors in heart failure and on the mechanisms of their activation and inactivation.

While working with Robert Lefkowitz at Duke University he discovered beta-arrestins, proteins that regulate the function of certain cell surface receptors.[3] He discovered that beta-1 adrenergic receptors and their regulatory G protein-coupled receptor kinases are dysregulated in heart failure.[4] The observation that increased β1-adrenergic receptor levels and signaling cause long-term cardiac damage contributed to the use of beta-blockers in heart failure patients.[5] Further studies by his lab showed that heart failure is accompanied by a specific type of activation of so-called ERK protein kinases (Extracellular signal-regulated kinases).[6] Another regulatory protein, Raf kinase inhibitor protein (RKIP), was shown to exert beneficial effects on cardiac structure and function.[7] Lohse pioneered the use of optical techniques to determine, where and how fast receptors become activated by hormones and neurotransmitters.[8][9][10] These studies led to the concept of nanometer-sized independent domains where signaling by individual receptors occurs.[11][12]

Awards

[edit]

He was awarded the Leibniz Award in 1999, the Ernst Jung Award for Medicine in 2000, and the Research Achievement Award of the International Society of Heart Research in 2007. From 2003 until 2008 he was a member of the German National Ethics Council. From 2009 to 2015 he was Vice President for Research of the University of Würzburg. From 2009 to 2019, he was Vice President of the German Academy of Sciences Leopoldina.[13][14] From 2019 to 2022 he served as President of the Society of German Natural Scientists and Physicians and organized its 200-year anniversary meeting in Leipzig in 2022.[15]

References

[edit]
  1. ^ "Martin Lohse wird Chef des Max-Delbrück-Centrums". Gesundheitsstadt Berlin (in German). 4 March 2016. Retrieved 27 November 2021.
  2. ^ "Wechsel im Vorstand des MDC". MDC Berlin (in German). Retrieved 27 November 2021.
  3. ^ Lohse, Martin J.; Benovic, Jeffrey L.; Codina, Juan; Caron, Marc G.; Lefkowitz, Robert J. (22 June 1990). "β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function". Science. 248 (4962). American Association for the Advancement of Science (AAAS): 1547–1550. Bibcode:1990Sci...248.1547L. doi:10.1126/science.2163110. ISSN 0036-8075. PMID 2163110.
  4. ^ Ungerer, M; Böhm, M; Elce, J S; Erdmann, E; Lohse, M J (1993). "Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart". Circulation. 87 (2). Ovid Technologies (Wolters Kluwer Health): 454–463. doi:10.1161/01.cir.87.2.454. ISSN 0009-7322. PMID 8381058.
  5. ^ Engelhardt, S.; Hein, L.; Wiesmann, F.; Lohse, M. J. (8 June 1999). "Progressive hypertrophy and heart failure in 1-adrenergic receptor transgenic mice". Proceedings of the National Academy of Sciences. 96 (12): 7059–7064. doi:10.1073/pnas.96.12.7059. ISSN 0027-8424. PMC 22055. PMID 10359838.
  6. ^ Lorenz, Kristina; Schmitt, Joachim P; Schmitteckert, Eva M; Lohse, Martin J (7 December 2008). "A new type of ERK1/2 autophosphorylation causes cardiac hypertrophy". Nature Medicine. 15 (1). Springer Science and Business Media LLC: 75–83. doi:10.1038/nm.1893. ISSN 1078-8956. PMID 19060905. S2CID 13973823.
  7. ^ Schmid, Evelyn; Neef, Stefan; Berlin, Christopher; Tomasovic, Angela; Kahlert, Katrin; Nordbeck, Peter; Deiss, Katharina; Denzinger, Sabrina; Herrmann, Sebastian; Wettwer, Erich; Weidendorfer, Markus; Becker, Daniel; Schäfer, Florian; Wagner, Nicole; Ergün, Süleyman; Schmitt, Joachim P; Katus, Hugo A; Weidemann, Frank; Ravens, Ursula; Maack, Christoph; Hein, Lutz; Ertl, Georg; Müller, Oliver J; Maier, Lars S; Lohse, Martin J; Lorenz, Kristina (19 October 2015). "Cardiac RKIP induces a beneficial β-adrenoceptor–dependent positive inotropy". Nature Medicine. 21 (11). Springer Science and Business Media LLC: 1298–1306. doi:10.1038/nm.3972. ISSN 1078-8956. PMID 26479924. S2CID 11418537.
  8. ^ Vilardaga, Jean-Pierre; Bünemann, Moritz; Krasel, Cornelius; Castro, Mariàn; Lohse, Martin J (15 June 2003). "Measurement of the millisecond activation switch of G protein–coupled receptors in living cells". Nature Biotechnology. 21 (7). Springer Science and Business Media LLC: 807–812. doi:10.1038/nbt838. ISSN 1087-0156. PMID 12808462. S2CID 19520338.
  9. ^ Hoffmann, Carsten; Gaietta, Guido; Bünemann, Moritz; Adams, Stephen R; Oberdorff-Maass, Silke; Behr, Björn; Vilardaga, Jean-Pierre; Tsien, Roger Y; Ellisman, Mark H; Lohse, Martin J (17 February 2005). "A FlAsH-based FRET approach to determine G protein–coupled receptor activation in living cells". Nature Methods. 2 (3). Springer Science and Business Media LLC: 171–176. doi:10.1038/nmeth742. ISSN 1548-7091. PMID 15782185. S2CID 6405686.
  10. ^ Lohse, Martin J.; Nuber, Susanne; Hoffmann, Carsten (8 March 2012). Christopoulos, Arthur (ed.). "Fluorescence/Bioluminescence Resonance Energy Transfer Techniques to Study G-Protein-Coupled Receptor Activation and Signaling". Pharmacological Reviews. 64 (2). American Society for Pharmacology & Experimental Therapeutics (ASPET): 299–336. doi:10.1124/pr.110.004309. ISSN 0031-6997. PMID 22407612. S2CID 2042851.
  11. ^ A. Bock, P. Annibale, C. Konrad, A. Hannawacker, S.E. Anton, I. Maiellaro, U. Zabel, S. Sivaramakrishnan, M. Falcke, M.J. Lohse: "Optical mapping of cAMP signaling at the nanometer scale." In: Cell. 182, 2020, pp. 1519-1530.
  12. ^ S.E. Anton, C. Kayser, I. Maiellaro, K. Nemec, J. Möller, A. Koschinski, M. Zaccolo, P. Annibale, M. Falcke, M.J. Lohse, A. Bock: "Receptor-associated independent cAMP nanodomains mediate spatiotemporal specificity of GPCR signaling." In: Cell. 185, 2022, pp. 1130-1142.
  13. ^ "Martin J. Lohse re-elected as Vice-President of the Leopoldina". Nationale Akademie der Wissenschaften Leopoldina. 6 October 2021. Retrieved 27 November 2021.
  14. ^ "Curriculum Vitae Prof. Dr. Martin J. Lohse" (PDF). www.leopoldina.org. Retrieved April 23, 2024.
  15. ^ Martin Lohse (Ed.): 'When the spark is lit. 200 years of the Society of German Natural Scientists and Physicians.' (in German) Passage-Verlag, Leipzig 2022, ISBN 978-3-95415-130-1
[edit]
Retrieved from "https://en.wikipedia.org/w/index.php?title=Martin_J._Lohse&oldid=1221064645"